SkyePharma PLC - Financial and Strategic Analysis Review

SkyePharma PLC - Financial and Strategic Analysis Review

Summary

SkyePharma PLC is a pharmaceutical company involved in R & D and manufacturing of drug delivery technologies, both for clinical studies and commercial sale. The company has eleven approved products in the areas of oral, inhalation and topical delivery. It provides the pharmaceutical industry with the tools to develop and commercialize new pharmaceutical products and patients with more effective and user-friendly treatments. The company's two major platforms technologies are oral and inhalation. It carries out its R&D operational activities through its subsidiaries in Muttenz, Switzerland and has production center located at Lyon, France.

This report presents an in-depth business, strategic and financial analysis of SkyePharma PLC. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and views on the company.

Scope

-The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.

-The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.

-The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.

-It provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.

-Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

-A quick "one-stop-shop" to understand the company.

-Enhance business/sales activities by understanding customers' businesses better.

-Get detailed information and financial & strategic analysis on companies operating in your industry.

-Identify prospective partners and suppliers - with key data on their businesses and locations.

-Capitalize on competitors' weaknesses and target the market opportunities available to them.

-Compare your company's financial trends with those of your peers / competitors.

-Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

http://www.companiesandmarkets.com/link.asp?id=05C1H8OEF73613

CONTACT: Mike King, Director, www.companiesandmarkets.com
Tel: +44 7813 784 393
Fax: +44 1536 790 144
e-mail: info@companiesandmarkets.com
WWW: http://www.companiesandmarkets.com/link.asp?id=05C1H8OEF73613

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

For full details on (SKYPY) SKYPY. (SKYPY) has Short Term PowerRatings at TradingMarkets. Details on (SKYPY) Short Term PowerRatings is available at This Link.